Reporting Recommendations for Tumor Marker Prognostic Studies

Lisa M. McShane, Biometric Research Branch, National Cancer Institute, Bethesda, MD Douglas G. Altman, Medical Statistics Group, Cancer Research UK, Centre for Statistics in Medicine, Wolfson College, Oxford, UK Willi Sauerbrei, Institut fuer Medizinische Biometrie und Medizinische Informatik, Universitaetsklinikum Freiburg, Freiburg, Germany Sheila E. Taube, Cancer Diagonisis Program, National Cancer Institute, Bethesda, MD Massimo Gion, Centro Regionale Indicatori Biochimici di Tumore, Ospedale Civile, Venezia, Italy Gary M. Clark, OSI Pharmaceuticals Inc, Boulder, CO For the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics

Reporting Recommendations for Tumor Marker Prognostic Studies | Litlas